Stanford Medicine

Researchers used artificial intelligence to predict the activity of thousands of genes in tumors based on routinely collected images of tumor biopsies. It could guide treatment without costly genomic tests.

Stanford Medicine launches a pilot program collaboration to expand its CME courses to a broader audience worldwide, setting a new standard for online medical education.

CAR-T cells show promise against pediatric diffuse midline gliomas, brain and spinal cord tumors that are among the deadliest cancers, a Stanford Medicine trial found.

Why do some people develop severe flu symptoms? A Stanford Medicine study points the finger at an unsung portion of the antibodies our immune systems generate to fend off invading pathogens.

Tiny circles called ecDNA are critical in cancer development and drug resistance. An international Stanford Medicine-led team publishes landmark studies detailing new findings and potential therapies.

Artificial intelligence and digital technology experts convened to discuss the benefits, challenges and potential of a digitally driven future in biomedical research and health care.

Blood tests for colorectal cancer are an option for patients who would otherwise not be screened, but they are not as effective as colonoscopies or stool tests, a Stanford Medicine-led study found.

The goal of the Clinical and Translational Science Award is to convert new treatments into care more rapidly.

Stanford researchers hope new technique will flip lymphoma protein’s normal action — from preventing cell death to triggering it.

Konstantina Stankovic and David Studdert join the distinguished society of scientists.

Some patients hospitalized for an emergency illness or injury will develop mental health problems months after the experience. A new screening tool can anticipate who’s most at risk.